Published in J Biol Stand on October 01, 1981
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol (2001) 3.05
Immunity to influenza A H9N2 viruses induced by infection and vaccination. J Virol (2001) 1.32
Conserved and host-specific features of influenza virion architecture. Nat Commun (2014) 1.15
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity. PLoS One (2012) 1.05
Thermal denaturation of influenza virus and its relationship to membrane fusion. Biochem J (2002) 0.86
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res (2002) 4.85
Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA (2001) 4.38
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol (1972) 2.78
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med (1995) 2.23
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine (1994) 2.09
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG (2000) 1.88
Simian virus 40-induced T and tumor antigens. J Virol (1969) 1.76
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Immunological and physicochemical studies of influenza matrix (M) polypeptides. Virology (1976) 1.66
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res Hum Retroviruses (1992) 1.60
Clonal variants of PC12 pheochromocytoma cells with defects in cAMP-dependent protein kinases induce ornithine decarboxylase in response to nerve growth factor but not to adenosine agonists. Mol Cell Biol (1985) 1.57
Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J Gen Virol (1975) 1.51
Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet (1971) 1.49
Studies on the mechanism of influenza virus entry into cells. J Gen Virol (1979) 1.46
Evidence for antigenic variation in influenza A nucleoprotein. Virology (1979) 1.43
Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS (1991) 1.39
Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment. Bull World Health Organ (1969) 1.38
Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68. J Hyg (Lond) (1970) 1.37
Immunofluorescent studies on the inhibition of influenza A and B viruses in mammalian cell cultures by amines and ammonium compounds. J Gen Virol (1968) 1.37
The intracellular distribution of influenza virus matrix protein and nucleoprotein in infected cells and their relationship to haemagglutinin in the plasma membrane. J Gen Virol (1988) 1.35
Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses (1993) 1.34
Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis (1978) 1.33
Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature (1977) 1.30
Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis. J Hyg (Lond) (1982) 1.25
In vivo selection of an influenza A2 strain resistant to amantadine. Nature (1970) 1.24
Antiviral activity of amantadine: a review of laboratory and clinical data. Pharmacol Ther (1980) 1.21
Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology (1989) 1.20
Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol (1991) 1.18
Ground penetrating radar surveys to locate 1918 Spanish flu victims in permafrost. J Forensic Sci (2000) 1.14
Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK). Bull World Health Organ (1987) 1.13
Detection of two antigenic subpopulations of A(H1N1) influenza viruses from pigs: antigenic drift or interspecies transmission? J Med Virol (1991) 1.12
Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection. J Hyg (Lond) (1981) 1.09
Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature (1978) 1.09
Antigenic and sequence analysis of H3 influenza virus haemagglutinins from pigs in Italy. J Gen Virol (1994) 1.09
Polypeptide composition of Influenza B viruses and enzymes associated with the purified virus particles. J Virol (1973) 1.09
Perioperative management of clopidogrel therapy: the effects on in-hospital cardiac morbidity in older patients with hip fractures. Br J Anaesth (2011) 1.08
A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic. J R Coll Gen Pract (1971) 1.07
Influenza RNA transcriptase inhibitors: studies in vitro and in vivo. Ann N Y Acad Sci (1977) 1.07
Comparison of transformation and T antigen induction in human cell lines. J Virol (1970) 1.07
Naturally occurring temperature-sensitive influenza A viruses of the H1N1 and H3N2 subtypes. J Gen Virol (1980) 1.06
Specific tumour antigen induced by chick embryo lethal orphan (CELO) virus. J Gen Virol (1969) 1.06
Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates. J Antimicrob Chemother (1986) 1.01
Who's that lady? Nat Med (1999) 1.00
The interaction of influenza virus haemagglutinin with phospholipid vesicles - morphological and immunological studies. J Gen Virol (1981) 1.00
Immunity to influenza. Dev Biol Stand (1975) 0.99
Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp Neurol (1998) 0.99
An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses. J Hyg (Lond) (1984) 0.99
Assessing the significance of reverse transcriptase activity in chick cell-derived vaccines. Biologicals (1997) 0.99
An antigenic analysis using monoclonal antibodies of influenza A (H3N2) viruses isolated from an epidemic in a semi-closed community. J Gen Virol (1986) 0.98
The growth of rubella virus in small laboratory animals. J Immunol (1967) 0.97
Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody. J Hyg (Lond) (1981) 0.97
Sequence analysis of the equine H7 influenza virus haemagglutinin gene. Virus Res (1992) 0.96
Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents. J Gen Virol (1974) 0.96
Growth of rubella virus in the hamster (Mesocricetus auratus). Virology (1966) 0.95
A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch Virol (1990) 0.95
Biochemical and serological studies of influenza B viruses: comparisons of historical and recent isolates. Virus Res (1984) 0.95
The role of humoral immunity in host defence against influenza A infection in mice. Postgrad Med J (1976) 0.94
Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. Vaccine (2006) 0.94
Immunological relationships of some oncogenic DNA viruses. I. Transplantation immunity studies. Arch Gesamte Virusforsch (1969) 0.94
What is the true nature of epidemic influenza virus and how do new epidemic viruses spread? Epidemiol Infect (1987) 0.93
Inhibition of the growth of influenza and rubella viruses by amines and ammonium salts. Br J Exp Pathol (1967) 0.92
Adenosine inhibits cell division and promotes neurite extension in PC12 cells. J Cell Physiol (1984) 0.91
Rapid antibody response to influenza vaccination in "at risk" groups. Vaccine (2000) 0.91
Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy. J Med Primatol (1993) 0.91
Failure of influenza vaccine to prevent two successive outbreaks of influenza A H1N1 in a school community. Br J Gen Pract (1990) 0.90
Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS. AIDS (1992) 0.90
Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Res Hum Retroviruses (1994) 0.90
Quantification of influenza virus structural proteins using rocket immunoelectrophoresis. J Gen Virol (1978) 0.90
New biochemical and clinical approaches to the control of epidemic influenza virus? J Antimicrob Chemother (1982) 0.90
Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro. J Med Virol (1992) 0.90
Effects of 1-beta-D-ribofuranosyl 1, 2, 4-triazole-3-carboxamide on influenza virus replication and polypeptide synthesis. J Antimicrob Chemother (1975) 0.89
Aminoadamantane-resistant strains of influenza A2 virus. J Hyg (Lond) (1973) 0.89
Inhibition of herpes virus by a new compound--acyclic guanosine. J Antimicrob Chemother (1979) 0.88
In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. Ann Rheum Dis (1988) 0.88
An immunologic marker technique for the Cendehill vaccine strain of rubella virus. J Immunol (1970) 0.88
Antigenic and biochemical heterogeneity of influenza A viruses. NIPH Ann (1980) 0.86
Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition. J Gen Virol (1991) 0.86
Transplantation immunity following immunization with extracts of adenovirus 12 tumour cells. Int J Cancer (1970) 0.86
An inhibitor of the particle-associated RNA-dependent RNA polymerase of influenza A and B viruses. J Gen Virol (1973) 0.85
IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination. J Infect Dis (1995) 0.85
Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. Proc Natl Acad Sci U S A (1989) 0.85
Cryptococcus gattii infection causing fulminant intracranial hypertension. Br J Anaesth (2007) 0.84
Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920. Virchows Arch (2003) 0.84
Biochemical and antigenic analysis using monoclonal antibodies of a series of of influenza A (H3N2) and (H1N1) virus reassortants. Vaccine (1986) 0.84
Evidence of diffusion artefacts in diaminobenzidine immunocytochemistry revealed during immune electron microscope studies of the early interactions between influenza virus and cells. J Virol Methods (1982) 0.83
Properties of transplantation antigen present in cell-free extracts of adenovirus-12 tumours. Eur J Cancer (1972) 0.83